News: commercialisation
VivaZome licenses University of ÑÇÖÞÉ«°É stem cell technology
VivaZome Therapeutics and the University of ÑÇÖÞÉ«°É have entered into a series of agreements encompassing licensing of technology, access to stem cells and conduct of research, all in support of VivaZome’s mission to develop and commercialise exosome-based therapeutics.
[Read more about VivaZome licenses University of ÑÇÖÞÉ«°É stem cell technology ]
New barley variety 'Laperouse' released
French barley breeding company SECOBRA is proud to release its first variety in Australia after many years of collaborative research and development with the University of ÑÇÖÞÉ«°É.
Amaero launches ÑÇÖÞÉ«°É 3D printing facility
Amaero International Limited (ASX:3DA), a world leader in metal additive manufacturing, officially launched their ÑÇÖÞÉ«°É facility today in partnership with the University of ÑÇÖÞÉ«°É. The facility was opened by the South Australian Minister for Innovation and Skills, the Hon. David Pisoni MP.
[Read more about Amaero launches ÑÇÖÞÉ«°É 3D printing facility]
Investors inject $45m into SA health and biotech industry
The ÑÇÖÞÉ«°É China Biotech Investment Fund has today been launched – a new $45 million investment fund that will accelerate the development and commercialisation of health and bio-technologies from South Australia for the global market.
[Read more about Investors inject $45m into SA health and biotech industry]
![RSS News Feed](/global/images/rss.gif" "RSS News Feed"){kind=small}